skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
gp100:154-162 Peptide Vaccine (Code C2764)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: gp100:154-162 Peptide Vaccine

Definition: A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance tumor-specific T-cell immunity. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells, and most melanoma lesions and is recognized via class I and II HLA-restricted mechanisms.

Label: gp100:154-162 Peptide Vaccine

NCI Thesaurus Code: C2764 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL053051  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
gp100:154-162 Peptide
gp100:154-162 Peptide Vaccine

External Source Codes: 
NSC Code 676540 (see NCI DTP info)
PDQ Closed Trial Search ID 630596
PDQ Open Trial Search ID 630596 (check for NCI PDQ open clinical trial info)
NCI META CUI CL053051

Other Properties:
     Name Value (qualifiers indented underneath)
code C2764
Legacy_Concept_Name gp100_154-162_Peptide
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2764

Mainbox Bottom